Japan to donate additional $800 million, vaccines to WHO's COVAX body: media
Reuters
Published Jun 02, 2021 02:57
TOKYO (Reuters) - Japanese Prime Minister Yoshihide Suga is planning to pledge an additional $800 million to the World Health Organisation's COVAX programme, which provides COVID-19 vaccines to countries in need, the Mainichi newspaper reported on Wednesday.
Japan has already pledged $200 million to COVAX, and the country is expected to announce donations of vaccine doses to the programme, the newspaper said without citing a source.
Suga will serve as host for an online COVAX summit on Wednesday, which will also be attended by United States Vice President Kamala Harris, philanthropist Bill Gates, and representatives from Group of Seven nations.
The summit is intended to fill a $1.7 billion funding gap, and it is hoped that countries and organisations will boost their pledges of money and vaccine doses, a Japanese government official told reporters on Tuesday.
Japanese lawmakers have urged giving supplies of AstraZeneca (NASDAQ:AZN) Plc's vaccine to Taiwan, which is dealing with a spike in domestic infections and has vaccinated less than 2% of its 23.5 million population. Japan has no immediate plans to use the AstraZeneca doses it has on hand and has secured enough supplies of other types of vaccine for its entire population.
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.